April 24, 2017 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

United BioPharma selects GE Healthcare’s FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals

CHALFONT ST. GILES, UK and HsinCHu, TAIWAN– 25 April 2017 – United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform to its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan. With this added capacity, UBP will support local healthcare needs by bringing... Read more

April 24, 2017 Clinical Research/Diagn. Microscopy

On-Demand Webinar: Quality with Confidence – What you need to know about digital microscopes for medical device quality processes

Digital microscopes – without eyepieces – are being used more frequently for quality inspection because of their ease of use, enhanced capabilities in 2D and 3D analysis, and reliable and repeatable results. This webinar from Leica will clear up common misconceptions about digital magnification, resolution and megapixels, and explain why optics in digital microscopes are... Read more

April 21, 2017 Clinical Research/Diagn. Lab Top-10 Mass Spectrometry Product Launch

Bruker Introduces New Clinical Microbiology Assays and Kits at ECCMID

VIENNA, April 21, 2017 /PRNewswire/ — At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker tomorrow will introduce important new clinical microbiology assays and consumables kits to further enhance the MALDI Biotyper® (MBT) platform.  Bruker will also introduce novel, real-time PCR assays and kits for fast molecular testing of invasive aspergillosis... Read more

April 20, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases

CAMBRIDGE, UK and SAN DIEGO, USA – April 20, 2017 – Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.... Read more

April 20, 2017 Clinical Research/Diagn. Informatics & Software Licensing, IP, and Legal Life Science Tools

Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

April 20, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10

Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock

Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published in the May 2017 print issue of Critical Care Medicine. Researchers from the study, titled “Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study,” investigated the use of... Read more

April 20, 2017 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Establishes Institute of Pathology at University Hospital Basel as Center of Excellence Partner

Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center of Excellence Program, a new initiative designed to develop and refine Thermo Fisher’s NGS-based research assays from its... Read more

April 20, 2017 Clinical Research/Diagn. PR/Corporate

Beckman Coulter Diagnostics Receives CE Mark and Expands Chemistry Me…

BREA, California  – April 20, 2017 Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis Beckman Coulter Diagnostics announced a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection and management of bacterial infections and sepsis. The high-quality, fully... Read more